公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Rapid and quantitative discrimination of tumour cells on tissue slices | KAI-WEN HUANG ; Chieh J.-J.; Liao S.-H.; Wei W.-C.; Hsiao P.-Y.; Yang H.-C.; Horng H.-E. | Nanotechnology | 2 | 1 | |
2020 | Recent advances: The imbalance of immune cells and cytokines in the pathogenesis of hepatocellular carcinoma | Jayant K.; Habib N.; KAI-WEN HUANG ; Warwick J.; Arasaradnam R. | Diagnostics | 16 | 14 | |
2015 | Signal analysis and liver tumor discrimination by using a high-Tc SQUID-based low-field NMR system in hospital | Liao S.-H.; Chieh J.-J.; Chou Y.-T.; Wang M.-W.; Chen H.-H.; KAI-WEN HUANG ; Yang H.-C.; Horng H.-E. | IEEE Transactions on Applied Superconductivity | 0 | 0 | |
2017 | Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis | TUNG-HUNG SU ; Shiau C.-W; Jao P; Yang N.-J; Tai W.-T; CHUN-JEN LIU ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; CHEN-HUA LIU ; KAI-WEN HUANG ; Hu T.-C; Huang Y.-J; YAO-MING WU ; Chen L.-J; PEI-JER CHEN ; DING-SHINN CHEN ; Chen K.-F; JIA-HORNG KAO | Scientific Reports | 12 | 11 | |
2015 | Sub-tesla-field magnetization of vibrated magnetic nanoreagents for screening tumor markers | Chieh J.-J.; KAI-WEN HUANG ; Shi J.-C. | Applied Physics Letters | 12 | 11 | |
2023 | Supplementary Figure 1 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG | American Association for Cancer Research | | | |
2023 | Supplementary Figure 2 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 3 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 4 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Figure 5 from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Legends from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2023 | Supplementary Tables from MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial | Debashis Sarker; Ruth Plummer; Tim Meyer; Mikael H. Sodergren; Bristi Basu; Cheng Ean Chee; KAI-WEN HUANG ; et al., | American Association for Cancer Research | | | |
2010 | Surgery for Boerhaave's syndrome with esophageal varices: Report of a case | Li C.-Y.; PEI-MING HUANG ; KAI-WEN HUANG ; Lee Y.-C. | Esophagus | 0 | 0 | |
2018 | A systematic review and meta-analysis comparing liver resection with the Rf-based device habib™-4X with the clamp-crush technique | Jayant K.; Sodergren M.H.; Reccia I.; Kusano T.; Zacharoulis D.; Spalding D.; Pai M.; Jiao L.R.; KAI-WEN HUANG | Cancers | 9 | 8 | |
2021 | Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer | Lin, Chun-Chi; Chen, Te-Hung; Wu, Yu-Chung; Fang, Chuan-Yin; Wang, Jaw-Yuan; Chen, Chou-Pin; KAI-WEN HUANG ; Jiang, Jeng-Kai | Annals of surgical oncology | 6 | 6 | |
2016 | Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth in Vivo | Yoon S.; KAI-WEN HUANG ; Reebye V.; Mintz P.; YU-WEN TIEN ; HONG-SHIEE LAI ; S?trom P.; Reccia I.; Swiderski P.; Armstrong B.; Jozwiak A.; Spalding D.; Jiao L.; Habib N.; Rossi J.J. | Molecular Therapy | 52 | 50 | |
2019 | Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC | Yoon S.; KAI-WEN HUANG ; Andrikakou P.; Vasconcelos D.; Swiderski P.; Reebye V.; Sodergren M.; Habib N.; Rossi J.J. | Molecular Therapy - Nucleic Acids | 21 | 16 | |
2014 | Theoretical and Experimental study of a circular imprint process for fabricating polylactide stents | Teng P.-T.; Chang F.-Y.; Lin M.-J.; YU-TING CHANG ; PO-CHIN LIANG ; KAI-WEN HUANG | Japanese Journal of Applied Physics | 0 | 0 | |
2014 | Time-evolution contrast of target MRI using high-stability antibody functionalized magnetic nanoparticles: An animal model | KAI-WEN HUANG ; Yang S.Y.; Horng H.E.; Chieh J.J.; Chen H.H.; CHAU-CHUNG WU ; Chen J.H.; Lin I.T.; Yang C.C.; Yang H.C. | Journal of Nanomaterials | 5 | 2 | |
2011 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients | CHEN-HUA LIU ; Liang, Cheng-Chao; KAI-WEN HUANG ; CHUN-JEN LIU ; Chen, Shih-I; JOU-WEI LIN ; Hung, Peir-Haur; Tsai, Hung-Bin; Lai, Ming-Yang; PEI-JER CHEN ; Chen, Jun-Herng; DING-SHINN CHEN ; JIA-HORNG KAO | Clinical journal of the American Society of Nephrology : CJASN | 71 | 69 | |